CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases
NCT: NCT05546606 · TERMINATED
Brief Summary
The aim of the study is to determine which standard of care strategy will best benefit very severe Acute Exacerbation (AE) of Chronic Obstructive Pulmonary Disease (COPD), single versus reinforced with ECCO2R and assess the respective efficacy and the safety. Very severe AE of COPD will be defined by high risk of Non-Invasive Ventilation (NIV) failure defined by need of intubation and/or in-Intensive Care Unit (ICU) mortality (Stratum 1) or by Invasive Mechanical Ventilation (IMV) after NIV failure and/or with severe hyperinflation and hypercapnia (Stratum 2).
Frequently Asked Questions
What is CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases?
CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases is a clinical trial registered under NCT05546606. Current status: TERMINATED.
What is the status of NCT05546606?
The current status of NCT05546606 (CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases) is: TERMINATED.
When did CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases start?
CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases started on 2023-04-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.